{
  "contract_version": "supplier-contract-v0.1",
  "project": "col-901831",
  "supplier_group_id": "ANHUI_KANGDA",
  "generated_at": "2026-04-13T12:22:31.598Z",
  "model": "gpt-4.1-mini",
  "provider_stack": [
    "openai"
  ],
  "narratives": {
    "positioning_summary": "ANHUI KANGDA 是 HS 9018312000 注射器品类 Tier A 中国供应商，在 2010–2015 年数据期中占据 1.07% 市场份额，目前处于退场阶段。",
    "buyer_strategy": "海外买家结构高度集中，Top1 买家 INDUSTRIAS CARDIOMED S.A.S. 占比 82.7%，对想替代它的中国对手意味着攻守难度极大，需集中火力攻克单一核心客户。",
    "pricing_read": "其加权均价为$0.0304/unit，比市场均价$0.0434/unit 低 29.8%，主战场在$0.0220–$0.0497 价格带，你从该价格带中端或略低位置切入最有机会。",
    "trend_read": "它最近一年比峰值掉了 9%，海外买家净减 2 家，处于退场状态。",
    "competitive_angles": {
      "strengths": [
        "Top1 买家 INDUSTRIAS CARDIOMED S.A.S. 贡献$1023K 营收",
        "出货批次达 40 批，历史数据覆盖 6 年",
        "直接电汇 74% 付款比例高，资金风险低"
      ],
      "weaknesses": [
        "Top1 买家占比 82.7%，客户依赖度过高",
        "CAGR 为-37.8%，业务规模持续萎缩",
        "价格带$0.0220–$0.0497 覆盖 97.7% 份额，利润空间被压缩"
      ],
      "how_to_attack": "优先抢 Top1 买家 INDUSTRIAS CARDIOMED S.A.S. 和已流失的 INJEC LTDA。使用$0.0220–$0.0497 价格带报价，略低于其$0.0304/unit 均价。强调 Medellin 港口 78% 的交付经验，提供直接电汇 74% 的付款条件以匹配其习惯。"
    },
    "buyer_opportunities": [
      {
        "buyer": "INDUSTRIAS CARDIOMED S.A.S.",
        "angle": "Top 依赖",
        "action": "本周联系该买家采购负责人，报价$0.0280/unit（低于其均价$0.0304），承诺 Medellin 港口优先发货。"
      },
      {
        "buyer": "INJEC LTDA",
        "angle": "流失",
        "action": "本周联系该买家，告知其原供应商 INJEC LTDA 峰值$33K 已降至$15K，报价$0.0250/unit 承接其$15K 订单。"
      },
      {
        "buyer": "INVERSIONES AMALGADENT LTDA",
        "angle": "Top 依赖",
        "action": "本周联系该买家，报价$0.0310/unit（略高于其$0.0304 均价但低于市场$0.0434），强调直接电汇 74% 的付款优势。"
      }
    ]
  }
}